Endocrinology

Understanding Acquired Hyperprolactinemia

At a Glance

Acquired hyperprolactinemia is a highly treatable condition characterized by high prolactin levels. It is most often caused by benign pituitary tumors called prolactinomas or certain medications. It is almost never cancer and usually responds very well to simple oral medications.

It is completely natural to feel a sense of alarm when you hear terms like “elevated brain hormones” or “pituitary mass.” For many patients, the initial emotional reaction to a diagnosis involving the brain is one of profound distress, often triggered by the fear of malignant cancer ^[1]. However, acquired hyperprolactinemia is a common endocrine condition that is highly manageable and almost never life-threatening ^[2]^[3].

This guide will walk you through everything you need to know about your condition. Please use the links below to navigate through the topics:

Symptoms and Complications of High Prolactin

Learn about the symptoms of high prolactin (hyperprolactinemia) for men and women. Understand hidden complications like bone loss and metabolic changes.

Root Causes: Why is My Prolactin High?

Learn the root causes of acquired hyperprolactinemia. Understand prolactinomas, the stalk effect, and how medications or thyroid issues cause high prolactin.

Decoding Your Prolactin Lab Results

Learn how to read your prolactin lab test results. Understand macroprolactin, the hook effect, false positives, and the prolactin-volume ratio (PVR).

Standard of Care: Treating High Prolactin

Learn about treatment options for high prolactin (hyperprolactinemia). Understand medications like cabergoline, side effects, and when surgery is needed.

Life After Treatment: Monitoring and Wellness

Learn about life after hyperprolactinemia treatment. Understand long-term monitoring, fertility recovery, bone health, cabergoline safety, and scanxiety.

Orienting to Your Diagnosis

Hyperprolactinemia is a condition where your blood contains higher-than-normal levels of prolactin, a hormone produced by the pituitary gland (a pea-sized organ at the base of your brain) ^[4]. While this hormone’s primary job is to stimulate breast milk production after childbirth, an “acquired” diagnosis means the elevation is caused by something other than natural processes like pregnancy or breastfeeding ^[5].

The most common causes of acquired hyperprolactinemia include:

Prolactinomas: Small, benign (non-cancerous) growths on the pituitary gland ^[3].
Medications: Certain antidepressants (SSRIs), antipsychotics, and blood pressure medications can interfere with dopamine, the chemical that normally keeps prolactin in check ^[4]^[6].
Other Health Conditions: An underactive thyroid (hypothyroidism) or kidney issues can also cause levels to rise ^[5].

Three Stabilizing Facts

When processing this news, it is helpful to keep these clinically supported facts in mind:

It is almost never cancer: Pituitary tumors (adenomas) are overwhelmingly benign. True pituitary cancer is exceedingly rare, representing only a tiny fraction of cases ^[3]^[7].
Medication is often the first and only step: Unlike many other “masses,” most prolactinomas respond remarkably well to simple oral medications called dopamine agonists (like cabergoline), which can shrink the tumor and normalize hormone levels without surgery ^[8]^[9].
Many “masses” stay small: Smaller growths, called microadenomas (less than 1cm), often have a stable natural history and may never grow or cause serious issues ^[10].

Defining Your Situation

Doctors distinguish between “physiological” and “acquired” hyperprolactinemia to ensure they aren’t treating a natural process.

Type	Cause	Clinical Context
Physiological	Normal body functions	Pregnancy, breastfeeding, or temporary spikes due to intense exercise or physical stress ^[5]^[11].
Genetic	Inherited DNA	Rare syndromes like Multiple Endocrine Neoplasia type 1 (MEN1).
Acquired	External or internal factors	Prolactin-secreting tumors, medications, or other underlying illnesses ^[4].

Current guidelines from the Endocrine Society emphasize that a single elevated blood test is often enough for diagnosis, provided the blood was drawn without the stress of multiple needle pokes, which can artificially raise levels ^[12]^[11]. If your lab results don’t match your symptoms, your doctor may test for macroprolactin, a harmless “large” version of the hormone that doesn’t require treatment ^[13]^[14].

Next Steps in Your Care

While the discovery of a pituitary mass is significant, the goal of treatment is typically to restore your quality of life, protect your vision, and balance your hormones ^[15]. Many patients find that keeping a personal log of symptoms and questions helps them feel more in control and improves communication with their endocrine team ^[16].

Common questions in this guide

What causes acquired hyperprolactinemia?

The most common causes are small, benign pituitary growths called prolactinomas. High prolactin can also be triggered by certain medications, an underactive thyroid, or underlying kidney issues.

Is a pituitary mass or prolactinoma a type of brain cancer?

No, prolactinomas are overwhelmingly benign, non-cancerous tumors. True pituitary cancer is exceedingly rare, and these growths are typically highly manageable without drastic interventions.

How is high prolactin usually treated?

Unlike many other masses, most cases respond remarkably well to simple oral medications called dopamine agonists, such as cabergoline. These medications can lower hormone levels and shrink pituitary tumors without the need for surgery.

What does it mean if my doctor found a microadenoma?

A microadenoma is a small pituitary mass that measures less than one centimeter in size. These small growths often remain completely stable over time and may never grow or cause serious health issues.

What is macroprolactin and why does it matter?

Macroprolactin is a harmless, larger version of the prolactin hormone that can sometimes elevate blood test results. If your lab results show high prolactin but you have no symptoms, your doctor may check for this to ensure you do not receive unnecessary treatment.

Curated prompts to bring to your next appointment.

1.What is my exact prolactin level, and was the blood draw done under 'stress-free' conditions?
2.Based on my lab results, do you recommend a screen for 'macroprolactin' to ensure this isn't a harmless form of the hormone?
3.Is the mass you found a 'microadenoma' (less than 1cm) or a 'macroadenoma' (over 1cm), and how does that change our plan?
4.Could any of my current medications or other health conditions, like hypothyroidism, be causing this elevation?
5.If we start medication like cabergoline, how soon can we expect my prolactin levels to normalize?

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References (16)

1
Work disability and its determinants in patients with pituitary tumor-related disease.
Lobatto DJ, Steffens ANV, Zamanipoor Najafabadi AH, et al.
Pituitary 2018; (21(6)):593-604 doi:10.1007/s11102-018-0913-3.
PMID: 30288666
2
The epidemiology of hyperprolactinaemia over 20 years in the Tayside region of Scotland: the Prolactin Epidemiology, Audit and Research Study (PROLEARS).
Soto-Pedre E, Newey PJ, Bevan JS, et al.
Clinical endocrinology 2017; (86(1)):60-67 doi:10.1111/cen.13156.
PMID: 27434534
3
[Current diagnosis and treatment of hyperprolactinemia].
Melgar V, Espinosa E, Sosa E, et al.
Revista medica del Instituto Mexicano del Seguro Social 2016; (54(1)):111-21.
PMID: 26820213
4
Determination of the frequency of hyperprolactinemia-related etiologies and the etiology-specific mean prolactin levels.
Korkmaz FN, Gökçay Canpolat A, Şahin M, Çorapçioğlu D
Minerva endocrinology 2024; (49(3)):243-252 doi:10.23736/S2724-6507.21.03386-8.
PMID: 34528777
5
Update on prolactinomas. Part 1: Clinical manifestations and diagnostic challenges.
Wong A, Eloy JA, Couldwell WT, Liu JK
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2015; (22(10)):1562-7.
PMID: 26256063
6
Etiology, presentation, and outcomes of hyperprolactinemia due to pituitary masses in children and adolescents.
Kilci F, Sarikaya E, Murat NÖ, Deniz A
Endocrine 2025; (88(2)):553-563 doi:10.1007/s12020-025-04176-0.
PMID: 39893604
7
Causes of hyperprolactinaemia in the primary care setting: How to optimise hyperprolactinaemia management.
García Cano AM, Jiménez Mendiguchía L, Rosillo Coronado M, et al.
Endocrinologia, diabetes y nutricion 2022; (69(10)):771-778 doi:10.1016/j.endien.2022.11.019.
PMID: 36526352
8
Management outcomes of prolactinoma: a retrospective study from Southern Iraq.
Alobaidy HF, Alidrisi HA, Reman KA, et al.
Journal of medicine and life 2025; (18(9)):869-877 doi:10.25122/jml-2025-0050.
PMID: 41178903
9
Decrease of Proliferative Potential and Vascular Density of Giant Prolactinoma in Patients Treated with Cabergoline.
Astaf'eva L, Shishkina L, Kalinin P, et al.
Asian journal of neurosurgery 2020; (15(2)):385-390 doi:10.4103/ajns.AJNS_16_20.
PMID: 32656137
10
Pituitary Adenoma Incidence, Management Trends, and Long-term Outcomes: A 30-Year Population-Based Analysis.
Graffeo CS, Yagnik KJ, Carlstrom LP, et al.
Mayo Clinic proceedings 2022; (97(10)):1861-1871 doi:10.1016/j.mayocp.2022.03.017.
PMID: 35753823
11
Serial prolactin sampling as a confirmatory test for true hyperprolactinemia.
Francés C, Boix E, Fajardo MT, Gómez-García JM
Endocrinologia, diabetes y nutricion 2020; (67(8)):525-529 doi:10.1016/j.endinu.2019.11.006.
PMID: 32113859
12
Role of Cannulated Prolactin Test in Evaluation of Hyperprolactinemia - A Retrospective Study.
Tsur A, Dreyfuss E, Ness-Abramof R, et al.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2020; (26(11)):1304-1311 doi:10.4158/EP-2020-0260.
PMID: 33471661
13
Pitfalls in the Diagnostic Evaluation of Hyperprolactinemia.
Vilar L, Vilar CF, Lyra R, Freitas MDC
Neuroendocrinology 2019; (109(1)):7-19 doi:10.1159/000499694.
PMID: 30889571
14
Establishment of reference intervals of monomeric prolactin to identify macroprolactinemia in Chinese patients with increased total prolactin.
Hu Y, Ni J, Zhang B, et al.
BMC endocrine disorders 2021; (21(1)):197 doi:10.1186/s12902-021-00861-z.
PMID: 34620143
15
Pituitary adenomas in children and young adults.
Krajewski KL, Rotermund R, Flitsch J
Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 2018; (34(9)):1691-1696 doi:10.1007/s00381-018-3853-3.
PMID: 29850940
16
The importance of personal documentation for patients living with long-term illness symptoms after pituitary surgery: A Constructivist Grounded Theory study.
Heckemann B, Graf T, Ung EJ, et al.
Health expectations : an international journal of public participation in health care and health policy 2023; (26(1)):226-236 doi:10.1111/hex.13648.
PMID: 36335563

This page provides an overview of acquired hyperprolactinemia for educational purposes only. Always consult your endocrinologist or healthcare provider for an accurate diagnosis and treatment plan tailored to your specific situation.

Get notified when new evidence is published on acquired hyperprolactinemia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Guide Contents